Cargando…

The auxiliary diagnostic value of prostate-specific antigen and α-methylacyl-CoA racemase in prostate cancer

Prostate cancer (PCa) is one of the most common types of malignant tumor, which places a major burden on the health of men, worldwide. A prerequisite to ensure good treatment outcomes for patients with PCa is an accurate diagnosis. The present study aimed to investigate the diagnostic value of prost...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Daijun, Shi, Xiang, Lei, Yu, Zhou, Xianrong, Chen, Qiuxiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377033/ https://www.ncbi.nlm.nih.gov/pubmed/32724384 http://dx.doi.org/10.3892/ol.2020.11658

Ejemplares similares

Diagnostic utility of a-methylacyl COA racemase in prostate cancer of the Iranian population
por: Taheri, Diana, et al.
Publicado: (2021)

Diagnostic utility of α-methylacyl CoA racemase (P504S) & HMWCK in morphologically difficult prostate cancer
por: Kumaresan, K, et al.
Publicado: (2010)

Gastric neuroendocrine carcinoma with positive staining for prostate cancer markers including prostate-specific antigen and alpha-methylacyl-CoA racemase
por: Hakozaki, Yuji, et al.
Publicado: (2018)

Exploiting the transcriptional specificity of the alpha-methylacyl-CoA racemase AMACR promoter for the molecular imaging of prostate cancer
por: Shapovalova, Mariya, et al.
Publicado: (2018)

Genetic Variations of α-Methylacyl-CoA Racemase Are Associated with Sporadic Prostate Cancer Risk in Ethnically Homogenous Koreans
por: Lee, Sang-Jin, et al.
Publicado: (2013)

Correction: Exploiting the transcriptional specificity of the alpha-methylacyl-CoA racemase AMACR promoter for the molecular imaging of prostate cancer
por: Shapovalova, Mariya, et al.
Publicado: (2019)

Expression and Characterization of α-Methylacyl CoA Racemase from Anisakis simplex Larvae
por: Kim, Bong Jin, et al.
Publicado: (2012)

Asymptomatic retinal dysfunction in alpha-methylacyl-CoA racemase deficiency
por: Alsalamah, Abrar K., et al.
Publicado: (2021)

α-methylacyl-CoA racemase (AMACR) expression in chordomas differentiates them from chondrosarcomas
por: Aviel-Ronen, Sarit, et al.
Publicado: (2016)

A-Methylacyl-CoA Racemase (AMACR) and Prostate-Cancer Risk: A Meta-Analysis of 4,385 Participants
por: Jiang, Ning, et al.
Publicado: (2013)

Diagnostic Value of Cytokeratin 34 beta E12 (Ck34βE12) and α-Methylacyl-CoA racemase (AMACR) Immunohistochemical Expression in Prostatic Lesions
por: Hasan, Ikram A., et al.
Publicado: (2020)

Prostate Cancer Diagnosis Using Urine Sediment Analysis-Based α-Methylacyl-CoA Racemase Score: A Single-Center Experience
por: Ji, Jin, et al.
Publicado: (2019)

Correction: A-Methylacyl-CoA Racemase (AMACR) and Prostate-Cancer Risk: A Meta-Analysis of 4,385 Participants
por: Jiang, Ning, et al.
Publicado: (2013)

Alpha-Methylacyl-CoA Racemase (AMACR), a Potential New Biomarker for Glioblastoma
por: Lee, Hyunji, et al.
Publicado: (2020)

α-Methylacyl-CoA racemase (AMACR) serves as a prognostic biomarker for the early recurrence/metastasis of HCC
por: Xu, Bo, et al.
Publicado: (2014)

Diagnostic Accuracy of Alpha-Methylacyl-CoA Racemase Immunohistochemical Expression for the Diagnosis of Ovarian and Endometrial Clear Cell Carcinomas
por: Nili, Fatemeh, et al.
Publicado: (2023)

MRI characterisation of adult onset alpha-methylacyl-coA racemase deficiency diagnosed by exome sequencing
por: Haugarvoll, Kristoffer, et al.
Publicado: (2013)

Autoantibody Positivity in Two Bahraini Siblings With a Novel Alpha-Methylacyl-CoA Racemase Mutation
por: Isa, Hasan M, et al.
Publicado: (2023)

Detection of Alpha-Methylacyl-CoA Racemase (AMACR), a Biomarker of Prostate Cancer, in Patient Blood Samples Using a Nanoparticle Electrochemical Biosensor
por: Lin, Po-Yuan, et al.
Publicado: (2012)

Suppression of α-methylacyl-coenzyme A racemase by miR200c inhibits prostate adenocarcinoma cell proliferation and migration
por: Xie, Hanbing, et al.
Publicado: (2020)

Aberrant expression and potency as a cancer immunotherapy target of alpha-methylacyl-coenzyme A racemase in prostate cancer
por: Honma, Ichiya, et al.
Publicado: (2009)

Significance of overexpression of alpha methylacyl-coenzyme A racemase in hepatocellular carcinoma
por: Li, Wei, et al.
Publicado: (2008)

Alpha-methylacyl-coenzyme A racemase expression in neuroendocrine neoplasms of the stomach
por: Annenkov, Alexey, et al.
Publicado: (2012)

Combined α-methylacyl-CoA racemase inhibition and docetaxel treatment reduce cell proliferation and decrease expression of heat shock protein 27 in androgen receptor-variant-7–positive prostate cancer cells
por: Yoshizawa, Atsuhiko, et al.
Publicado: (2021)

Alpha-Methylacyl-Coenzyme A Racemase-Expressing Urachal Adenocarcinoma of the Abdominal Wall
por: Ha, Yun-Sok, et al.
Publicado: (2010)

Increased expression of α-methylacyl-coenzyme A racemase (AMACR; p504s) and p16 in distal hyperplastic polyps
por: Dayi, Nimet, et al.
Publicado: (2013)

Pseudohyperplastic variant of adenocarcinoma as a component of α-methyl–CoA-racemase (AMACR negative) carcinosarcoma of the prostate
por: Dudani, Sharmila, et al.
Publicado: (2015)

Current Knowledge on the Function of α-Methyl Acyl-CoA Racemase in Human Diseases
por: Kong, Gyeyeong, et al.
Publicado: (2020)

Corrigendum: Current Knowledge on the Function of α-Methyl Acyl-CoA Racemase in Human Diseases
por: Kong, Gyeyeong, et al.
Publicado: (2021)

Oncogenic Activity of Solute Carrier Family 45 Member 2 and Alpha‐Methylacyl‐Coenzyme A Racemase Gene Fusion Is Mediated by Mitogen‐Activated Protein Kinase
por: Zuo, Ze‐Hua, et al.
Publicado: (2021)

Potential diagnostic value of multiple indicators combined with total prostate-specific antigen in prostate cancer
por: Zhang, Qingxu, et al.
Publicado: (2023)

Diagnostic value of prostate-specific antigen in women with polycystic ovary syndrome*
por: Mardanian, Farahnaz, et al.
Publicado: (2011)

Netrin 1 and Alpha-Methyl Acylcoenzim-A Racemase in diagnosis of prostate cancer
por: Koseoglu, Ersin, et al.
Publicado: (2018)

Age-specific prostate specific antigen and prostate specific antigen density values in a community-based Indian population
por: Ganpule, Arvind P., et al.
Publicado: (2007)

Value of serum free prostate-specific antigen density in the diagnosis of prostate cancer
por: Zou, Bing-Zi, et al.
Publicado: (2023)

Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies
por: Ben Jemaa , Awatef, et al.
Publicado: (2010)

Prostate-specific antigen density values among patients with symptomatic prostatic enlargement in Nigeria
por: Udeh, Emeka I., et al.
Publicado: (2016)

The Value of Prostate-Specific Antigen-Related Indexes and Imaging Screening in the Diagnosis of Prostate Cancer
por: Bai, Xiaojing, et al.
Publicado: (2020)

PROSTATE-SPECIFIC ANTIGEN (PSA) VALUES IN PATIENTS WITH LOW- AND HIGH-RISK PROSTATIC ADENOCARCINOMA
por: Mašić, Silvija, et al.
Publicado: (2019)

Prostate specific antigen /
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_eikh88g3g2nubkrov2425mhm1j